About

Sleep disorders are estimated to affect 50 to 70 million Americans. Up to 23 million people in the United States suffer from sleep apnea with 82% undiagnosed. That adds up to an annual economic cost of up to $165 billion dollars. Chronic obstructive pulmonary disease (COPD) is taking a toll on the US population as well. It’s estimated that there are up to 24 million people in the US with impaired lung function consistent with COPD, leading to $50 billion in annual economic costs.

Health care providers caring for patients with chronic conditions such as sleep apnea and COPD struggle with a collective problem—siloed data. Siloed data in disparate systems creates barriers to patient care.

Somnoware solves this problem through a web-based platform for enhanced respiratory care management. The platform orchestrates data flow between 100+ medical devices, unifies datasets within a single platform, delivers high-impact analytics, enables faster diagnosis, proactive intervention, & automated patient engagement.

By streamlining diagnostic testing workflows and driving greater therapy adherence, our customers are improving treatment outcomes. More than 1,500 diagnostic testing centers use Somnoware, providing more than 1 million sleep studies annually.